返回 Agenda
Session 5, Part 2: The Paradigm Shift: from Treatment to Prevention
Session Chair(s)
Michael Forstner, PHD, MPH, MSC
Managing Director, Head of Pharmacoepidemiology Practice
Mesa Laubela-Consulting, Switzerland
Maria Raad
Vice President, Customer and Digital Strategy
Janssen EMEA Commercial, Switzerland
Session 5, Part 2: The Paradigm Shift: from Treatment to Prevention
Speaker(s)
Setting the Scene: Digital Biomarkers in Clinical Research from a Pharma Industry Perspective
Christian Gossens, PHD
F. Hoffmann-La Roche Ltd., Switzerland
Global Area Head, Digital Biomarker Informatics
Panel Discussion: Where are we with Digital Biomarkers for Disease Monitoring?
Foteini Orfaniotou
F. Hoffmann-La Roche Ltd., Switzerland
Group Digital Health Leader
Christian Gossens, PHD
F. Hoffmann-La Roche Ltd., Switzerland
Global Area Head, Digital Biomarker Informatics
Trishna Bharadia
The Spark Global, United Kingdom
Patient Advocate, International Speaker, Writer, Advisor and Content Reviewer
Marcus D'Souza
University Hospital Basel, Switzerland
Head Neurostatus-UHB